We are live on ! Find out more
WE

Wealth Effects Portfolio holdings

AUM $282M
1-Year Est. Return 62.81%
This Fund
S&P 500
This Quarter Est. Return
+0.47%
1 Year Est. Return
+62.81%
3 Year Est. Return
+160.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$282M
AUM Growth
-$37.6M
Cap. Flow
-$28.7M
Cap. Flow %
-10.18%
Top 10 Hldgs %
41.01%
Holding
252
New
34
Increased
88
Reduced
57
Closed
14

Top Buys

1
ALAB icon
Astera Labs
ALAB
+$2.1M
2
RBRK icon
Rubrik
RBRK
+$2.01M
3
MELI icon
Mercado Libre
MELI
+$1.79M
4
BX icon
Blackstone
BX
+$758K
5
JQC icon
Nuveen Credit Strategies Income Fund
JQC
+$620K

Top Sells

1
AVDL
Avadel Pharmaceuticals
AVDL
+$40.8M
2
TTD icon
Trade Desk
TTD
+$1.1M
3
ESTC icon
Elastic
ESTC
+$792K
4
BSTZ icon
BlackRock Science and Technology Term Trust
BSTZ
+$698K
5
CLS icon
Celestica
CLS
+$599K

Sector Composition

1 Technology 30.87%
2 Healthcare 8.62%
3 Financials 8.03%
4 Consumer Discretionary 7.23%
5 Communication Services 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STXS icon
226
Stereotaxis
STXS
$154M
$126K 0.04%
68,500
-560
-0.8% -$1.23K
HUMA icon
227
Humacyte
HUMA
$179M
$124K 0.04%
204,500
+51,433
+34% +$53.5K
ETJ
228
Eaton Vance Risk-Managed Diversified Equity Income Fund
ETJ
$561M
$123K 0.04%
15,075
-75
-0.5% -$649
SMR icon
229
NuScale Power
SMR
$2.67B
$114K 0.04%
+10,500
New +$160K
PML
230
PIMCO Municipal Income Fund II
PML
$501M
$114K 0.04%
+15,000
New +$115K
SCYX icon
231
SCYNEXIS
SCYX
$42.4M
$80.2K 0.03%
10,938
-500
-4% -$3.09K
OGN icon
232
Organon & Co
OGN
$3.55B
$74.9K 0.03%
+12,512
New +$94.1K
INDI icon
233
indie Semiconductor
INDI
$809M
$64.4K 0.02%
20,000
-200
-1% -$706
LODE icon
234
Comstock
LODE
$298M
$33.5K 0.01%
+11,000
New +$36K
AKBA icon
235
Akebia Therapeutics
AKBA
$359M
$22.2K 0.01%
16,000
– –
XAIR icon
236
Beyond Air
XAIR
$4.02M
$19.6K 0.01%
1,418
-166
-10% -$3.52K
AUTL
237
Autolus Therapeutics
AUTL
$383M
$13.8K ﹤0.01%
10,000
– –
ARKK icon
238
ARK Innovation ETF
ARKK
$6.15B
– –
-2,893
Closed -$223K
AVDL
239
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
– –
0
– -$431K
AVDL
240
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-1,891,917
Closed -$40.8M
BLK icon
241
Blackrock
BLK
$166B
– –
-384
Closed -$411K
BSTZ icon
242
BlackRock Science and Technology Term Trust
BSTZ
$1.9B
– –
-30,886
Closed -$698K
CLS icon
243
Celestica
CLS
$34.6B
– –
-2,025
Closed -$599K
CMI icon
244
Cummins
CMI
$89.5B
– –
-511
Closed -$261K
DIS icon
245
Walt Disney
DIS
$170B
– –
-2,755
Closed -$313K
GEHC icon
246
GE HealthCare
GEHC
$28.7B
– –
-2,636
Closed -$216K
HOOD icon
247
Robinhood
HOOD
$89.7B
– –
-3,090
Closed -$349K
PPLT
248
abrdn Physical Platinum Shares ETF
PPLT
$1.82B
– –
-20,000
Closed -$373K
ECHO
249
EchoStar
ECHO
$26.7B
– –
-3,600
Closed -$391K
STKL
250
DELISTED
SunOpta
STKL
– –
-24,500
Closed -$93.1K
7 8 9
10
11

Similar funds

SIC
Samalin Investment Counsel Chappaqua, New York $282M AUM 16.72% 1-Year Est. Return
DRD
Dennis R. Delaney $282M AUM 16.32% 1-Year Est. Return
II
INCA Investments Miami, Florida $282M AUM 42.53% 1-Year Est. Return
3CP
3G Capital Partners New York $282M AUM 22.21% 1-Year Est. Return
MFG
Monte Financial Group Guilford, Connecticut $282M AUM 14.97% 1-Year Est. Return
TC
TAGStone Capital Charlotte, North Carolina $283M AUM 14.51% 1-Year Est. Return
UFAC
Urban Financial Advisory Corp Chicago, Illinois $283M AUM 13.45% 1-Year Est. Return
TPW
Tiller Private Wealth Bethlehem, Pennsylvania $281M AUM 16.29% 1-Year Est. Return

Wealth Effects's Q1 2026 Portfolio in Review

As of Q1 2026, Wealth Effects held 252 positions worth $282M, down 12% from $320M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Wealth Effects withdrew a net $28.7M in Q1 2026, closing 14 positions and reducing 57 holdings. Its most notable exit was Avadel Pharmaceuticals, an estimated $40.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Wealth Effects opened a new position in Astera Labs worth $1.62M.

  • Wealth Effects's largest Q1 2026 buy was Astera Labs: 14,765 shares worth $1.62M.
  • Wealth Effects added most to Mercado Libre in Q1 2026, an estimated $1.79M increase.
  • Wealth Effects's biggest Q1 2026 reduction was Elastic, cutting an estimated $792K.
  • Wealth Effects fully exited Avadel Pharmaceuticals in Q1 2026, selling an estimated $40.8M.
  • Wealth Effects's ten largest holdings make up 41% of its $282M portfolio in Q1 2026.
  • Wealth Effects opened 34 new positions and closed 14 in Q1 2026.
  • Wealth Effects's portfolio value fell 12% quarter-over-quarter to $282M.

Based on Wealth Effects's 13F filing for Q1 2026, filed 21 Apr 2026.